RCAMU
HZNP

Rothschild & Co Asset Management US’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$45.9M Sell
403,734
-24,972
-6% -$2.84M 0.7% 49
2022
Q3
$26.5M Sell
428,706
-13,725
-3% -$849K 0.45% 66
2022
Q2
$35.3M Buy
442,431
+20,248
+5% +$1.61M 0.54% 54
2022
Q1
$44.4M Buy
422,183
+156,549
+59% +$16.5M 0.57% 51
2021
Q4
$28.6M Sell
265,634
-2,728
-1% -$294K 0.34% 73
2021
Q3
$29.4M Sell
268,362
-18,401
-6% -$2.02M 0.36% 66
2021
Q2
$26.9M Sell
286,763
-142,901
-33% -$13.4M 0.32% 82
2021
Q1
$39.5M Sell
429,664
-176,681
-29% -$16.3M 0.49% 54
2020
Q4
$44.4M Sell
606,345
-129,104
-18% -$9.44M 0.57% 49
2020
Q3
$57.1M Sell
735,449
-162,964
-18% -$12.7M 1.03% 10
2020
Q2
$49.9M Sell
898,413
-537,821
-37% -$29.9M 0.74% 26
2020
Q1
$42.5M Sell
1,436,234
-268,367
-16% -$7.95M 0.66% 36
2019
Q4
$61.7M Sell
1,704,601
-166,811
-9% -$6.04M 0.64% 29
2019
Q3
$51M Buy
1,871,412
+173,738
+10% +$4.73M 0.55% 37
2019
Q2
$40.8M Buy
1,697,674
+83,247
+5% +$2M 0.44% 77
2019
Q1
$42.7M Sell
1,614,427
-47,923
-3% -$1.27M 0.46% 69
2018
Q4
$32.5M Buy
1,662,350
+10,573
+0.6% +$207K 0.39% 81
2018
Q3
$32.3M Sell
1,651,777
-29,414
-2% -$576K 0.33% 116
2018
Q2
$27.8M Sell
1,681,191
-14,369
-0.8% -$238K 0.3% 145
2018
Q1
$24.1M Sell
1,695,560
-48,035
-3% -$682K 0.27% 157
2017
Q4
$25.5M Sell
1,743,595
-63,534
-4% -$928K 0.27% 158
2017
Q3
$22.9M Buy
1,807,129
+330,424
+22% +$4.19M 0.25% 170
2017
Q2
$17.5M Buy
1,476,705
+265,013
+22% +$3.15M 0.2% 194
2017
Q1
$17.9M Buy
1,211,692
+11,189
+0.9% +$165K 0.21% 194
2016
Q4
$19.4M Buy
1,200,503
+287,373
+31% +$4.65M 0.25% 163
2016
Q3
$16.6M Buy
913,130
+395,830
+77% +$7.18M 0.28% 146
2016
Q2
$8.52M Buy
517,300
+87,875
+20% +$1.45M 0.15% 220
2016
Q1
$7.12M Buy
429,425
+7,351
+2% +$122K 0.13% 227
2015
Q4
$9.15M Sell
422,074
-9,965
-2% -$216K 0.17% 198
2015
Q3
$8.56M Sell
432,039
-21,331
-5% -$423K 0.17% 202
2015
Q2
$15.8M Buy
+453,370
New +$15.8M 0.29% 117